Tamim Niazi, MDCM, on Prostate Cancer: Results From a Trial on Dose Escalation

2017 ASTRO Annual Meeting
Tweet this page

Tamim Niazi, MDCM, of McGill University, discusses phase III study findings on hypofractionated, dose-escalation radiation therapy for high-risk adenocarcinoma of the prostate (Abstract 281).

Advertisement

Advertisement



Advertisement